Rheinmetall's €250m Lithuanian Base Highlights a Familiar Paradox: Record Orders, Falling Shares

Rheinmetall's shares trade 44% below peak despite €80.5bn backlog and strong Q2 results, as F126 cancellation and guidance cut weigh on sentiment.

The defence giant's latest infrastructure win — a €250m modular military camp in Lithuania capable of housing 2,000 troops, plus roughly €40m per year in operating and support services — extends a run of contract announcements that would flatter most European industrials. Yet the share price keeps telling a different story, trading at €1,123.80, some 44 percent below the €2,007.00 peak struck in early October.

That gap between operational momentum and market sentiment has become the defining feature of Rheinmetall's year. The stock has shed 28 percent since January, with a 7.3 percent decline in the past week alone. Even a 25 percent recovery from June's 52-week low of €902.50 has done little to restore investor confidence.

The order pipeline, by contrast, shows no such weakness. The Bundeswehr recently added 149 mobile medical stations worth over €500m to an existing framework agreement signed in late 2024, with production slated to begin in the first quarter of 2027. Early August brought a memorandum of understanding with Lockheed Martin for joint production of ATACMS guided missiles at the Unterluess plant, where manufacturing lines are expected from 2027. And in a demonstration of its expanding technological footprint, Rheinmetall and Hensoldt showcased the integration of passive sensor technology into an air defence system at the Timber Express 2026 exercise in Manching, days after the first launch of the FV-014 loitering munition system from the company's own Containerized Missile Launcher mounted on an HX truck.

The backlog tells the same story: €80.5bn as of June 30, up from €56.0bn a year earlier. Second-quarter revenue climbed 69.8 percent to €3,289m, with operating profit jumping 115 percent to €562m and a margin of 17.1 percent. For the full year, management guides to sales between €13.7bn and €14.2bn with an operating margin around 19 percent — figures that already account for the cancellation of the F126 frigate programme.

That cancellation, which triggered writedowns of roughly €2bn and briefly knocked almost 20 percent off the share price, also forced the company to trim its 2026 revenue outlook. The financial fallout is visible in the cash flow statement: operating free cash flow swung to minus €1,616m in the first half, compared with minus €631m a year earlier, with the second quarter alone contributing minus €1,331m.

The analyst community remains split on valuation. RBC initiated coverage on August 11 with an "Outperform" rating and a €1,600 price target — the most bullish call on the street — while Jefferies lifted its target from €1,300 to €1,350 on August 14, maintaining a "Buy". The chasm between those targets and the current price underscores the scepticism that has taken hold since the F126 reversal and the subsequent guidance cut roughly three weeks ago, after which the shares have slipped about 2.1 percent.

All eyes now turn to December 9, when the Bundestag votes on the so-called Arminius programme — a multibillion-euro order for Boxer armoured vehicles that market observers believe could more than offset the F126 hole. Before that, investors will parse the DZ Bank expert day, an upcoming event on the company's investor relations calendar that may offer clues on how durable the growth narrative truly appears to sell-side analysts.